Mitochondrial p32 Is a Critical Mediator of ARF-Induced Apoptosis

Cancer Cell

Volumn 13, Issue 6, 2008, Pages 542-553

  Itahana, Koji ^a   Zhang, Yanping ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CELLCYCLE

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MITOCHONDRIAL PROTEIN; MUTANT PROTEIN; PROTEIN P32;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEOPLASM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENSITIZATION;

EID: 44449129539     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.04.002     Document Type: Article

References (54)

1. Beatch M.D., Everitt J.C., Law L.J., and Hobman T.C. Interactions between rubella virus capsid and host protein p32 are important for virus replication. J. Virol. 79 (2005) 10807-10820
2. Chappell J.B., and Greville G.D. Effects of oligomycin on respiration and swelling of isolated liver mitochondria. Nature 190 (1961) 502-504
3. Dedio J., Jahnen-Dechent W., Bachmann M., and Muller-Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J. Immunol. 160 (1998) 3534-3542
4. ARF tumor suppressor. Genes Dev. 12 (1998) 2434-2442
5. Enomoto T., Lindstrom M.S., Jin A., Ke H., and Zhang Y. Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J. Biol. Chem. 281 (2006) 18463-18472
6. Eymin B., Leduc C., Coll J.L., Brambilla E., and Gazzeri S. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 22 (2003) 1822-1835
7. Ghebrehiwet B., Lim B.L., Peerschke E.I., Willis A.C., and Reid K.B. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179 (1994) 1809-1821
8. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
9. Greenblatt, M. (2006). UVM BioDesktop CDKN2a Database Project (http://biodesktop.uvm.edu/perl/p16).
10. Greenblatt M.S., Beaudet J.G., Gump J.R., Godin K.S., Trombley L., Koh J., and Bond J.P. Detailed computational study of p53 and p16: Using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncogene 22 (2003) 1150-1163
11. Hall K.T., Giles M.S., Calderwood M.A., Goodwin D.J., Matthews D.A., and Whitehouse A. The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76 (2002) 11612-11622
12. Hemmati P.G., Gillissen B., von Haefen C., Wendt J., Starck L., Guner D., Dorken B., and Daniel P.T. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 21 (2002) 3149-3161
13. Hemmati P.G., Guner D., Gillissen B., Wendt J., von Haefen C., Chinnadurai G., Dorken B., and Daniel P.T. Bak functionally complements for loss of Bax during p14(ARF)-induced mitochondrial apoptosis in human cancer cells. Oncogene 25 (2006) 6582-6594
14. Itahana K., Bhat K.P., Jin A., Itahana Y., Hawke D., Kobayashi R., and Zhang Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12 (2003) 1151-1164
15. Jiang X., and Wang X. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73 (2004) 87-106
16. Kamal A., and Datta K. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis 11 (2006) 861-874
17. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavitgian S.V., Stockert E., Day R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
18. ARF. Cell 91 (1997) 649-659
19. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M., and Sherr C.J. Functional and physical interaction of the ARF tumor suppressor with p53 and MDM2. Proc. Natl. Acad. Sci. USA 95 (1998) 8292-8297
20. Kim S.H., Mitchell M., Fujii H., Llanos S., and Peters G. Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc. Natl. Acad. Sci. USA 100 (2003) 211-216
21. Kim M., Sgagias M., Deng X., Jung Y.J., Rikiyama T., Lee K., Ouellette M., and Cowan K. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression. Biochem. Biophys. Res. Commun. 320 (2004) 138-144
22. Krainer A.R., Mayeda A., Kozak D., and Binns G. Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 66 (1991) 383-394
23. Krimpenfort P., Quon K.C., Mooi W.J., Loonstra A., and Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413 (2001) 83-86
24. Lindstrom M.S., Klangby U., Inoue R., Pisa P., Wiman K.G., and Asker C.E. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. Exp. Cell Res. 256 (2000) 400-410
25. ARF to p53 stabilization. Curr. Biol. 10 (2000) 539-542
26. Luo Y., Yu H., and Peterlin B.M. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68 (1994) 3850-3856
27. Midgley C.A., Desterro J.M., Saville M.K., Howard S., Sparks A., Hay R.T., and Lane D.P. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19 (2000) 2312-2323
28. Muta T., Kang D., Kitajima S., Fujiwara T., and Hamasaki N. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J. Biol. Chem. 272 (1997) 24363-24370
29. Nikolakaki E., Simos G., Georgatos S.D., and Giannakouros T. A nuclear envelope-associated kinase phosphorylates arginine-serine motifs and modulates interactions between the lamin B receptor and other nuclear proteins. J. Biol. Chem. 271 (1996) 8365-8372
30. Nobori T., Mlura K., Wu D.J., Lois A., Takabayashi K., and Carson D.A. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 (1994) 753-756
31. Petersen-Mahrt S.K., Estmer C., Ohrmalm C., Matthews D.A., Russell W.C., and Akusjarvi G. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 18 (1999) 1014-1024
32. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., and DePinho R.A. The INK4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92 (1998) 713-723
33. Quelle D.E., Zindy F., Ashmun R., and Sherr C.J. Alterative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83 (1995) 993-1000
34. ARF. Proc. Natl. Acad. Sci. USA 94 (1997) 3436-3440
35. Ramsby M.L., and Makowski G.S. Differential detergent fractionation of eukaryotic cells. Analysis by two-dimensional gel electrophoresis. Methods Mol. Biol. 112 (1999) 53-66
36. Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M., and Kimchi A. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol. Cell 22 (2006) 463-475
37. Reef S., Shifman O., Oren M., and Kimchi A. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene 26 (2007) 6677-6683
38. INK4a/CDK2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378 (1998) F115-F177
39. Rubinstein D.B., Stortchevoi A., Boosalis M., Ashfaq R., Ghebrehiwet B., Peerschke E.I., Calvo F., and Guillaume T. Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells. Int. J. Cancer 110 (2004) 741-750
40. Serrano M., Lee H.-W., Chin L., Cordon-Cardos C., Beach D., and DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 (1996) 27-37
41. Sharpless N.E. INK4a/ARF: A multifunctional tumor suppressor locus. Mutat. Res. 576 (2005) 22-38
42. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., and DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413 (2001) 86-91
43. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12 (1998) 2984-2991
44. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2 (2001) 731-737
45. Sherr C.J. Divorcing ARF and p53: An unsettled case. Nat. Rev. Cancer 6 (2006) 663-673
46. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17 (1998) 5001-5014
47. Sunayama J., Ando Y., Itoh N., Tomiyama A., Sakurada K., Sugiyama A., Kang D., Tashiro F., Gotoh Y., Kuchino Y., and Kitanaka C. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Cell Death Differ. 11 (2004) 771-781
48. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
49. Wang Y., Finan J.E., Middeldorp J.M., and Hayward S.D. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236 (1997) 18-29
50. Weber J.D., Kuo M.-L., Bothner B., Digiammarino E.L., Kriwacki R.W., Roussel M.F., and Sherr C.J. Cooperative signals governing ARF-MDM2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20 (2000) 2517-2528
51. Yarbrough W.G., Bessho M., Zanation A., Bisi J.E., and Xiong Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res. 62 (2002) 1171-1177
52. Zhang Y., Xiong Y., and Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92 (1998) 725-734
53. Zhang Y., and Xiong Y. Mutation in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3 (1999) 579-591
54. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., and Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12 (1998) 2424-2433